Browse the corpus
Walk the Even Hospital Database by book and chapter — the raw source passages that ground Ask, DDx, and the rest.
1 passage
©2013 UpToDate ® Print Email Approximate incidence of complete alopecia from selected combination chemotherapy regimens Regimen Reported incidence of alopecia (percent) Breast cancer AC 70 AC-T 100 CAF/FAC 43 CMF 10 FEC 50 20 FEC 100 79 TAC 98 Gastrointestinal malignancies FOLFIRI 25 to 42 FOLFOX 9 to 19 Lung cancer Carboplatin/etoposide 34 Cisplatin/etoposide 90 Paclitaxel/carboplatin 50 to 100 Lymphoma ABVD 24 to 31 BEACOPP 79 R-CHOP 45 to 90 AC: doxorubicin, cyclophosphamide; AC-T: doxorubicin, cyclophosphamide, paclitaxel; ABVD: doxorubicin, bleomycin, vincristine, dactinomycin; BEACOPP: bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone; CAF/FAC: cyclophosphamide, doxorubicin, fluorouracil; CMF: cyclophosphamide, methotrexate, fluorouracil; FEC: fluorouracil, epirubicin, cyclophosphamide; FOLFIRI: fluorouracil, leucovorin, irinotecan; FOLFOX: fluorouracil, leucovorin, oxaliplatin; R-CHOP: rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone; TAC: docetaxel, doxorubicin, cyclophosphamide.